VivoSeq
Gastroenterology

Postoperative Ileus

0

Pipeline Programs

1

Active Trials

1

Companies Involved

Postoperative Ileus is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

19

clinical trials

Completed16 · 84%
Unknown status2 · 11%
Recruiting1 · 5%

Trial Activity

19 trials

Prucalopride in Postoperative Ileus
Completed·UUniversity of Auckland, New Zealand·Phase 3·NCT02947269·150 enrolled
Thoracic Epidural for Postoperative Ileus
Completed·SSamsung Medical Center·N/A·NCT02491385·28 enrolled
Alvimopan as a Rescue Treatment of Postoperative Ileus
Completed··Phase 4·NCT04405037·65 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)